This announcement is a separate document:
中國再生醫學：主要交易有關出售以下公司之全部已發行股本(I)中國再生醫學組織工程有限公司及(II)中國再生醫院投資管理有限公司
CRMI: MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN (I) CHINA REGENERATIVE MEDICINE TISSUE ENGINEERING LIMITED AND (II) CHINA REGENERATIVE HOSPITAL INVESTMENT MANAGEMENT LIMITED
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated